Get startedLog in
    Picture of Genscript Biotech logo

    1548 — Genscript Biotech News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapNeutral
    All News

    Brief: Genscript Biotech Says Legend Biotech Filed A Form 6-K With U.S. SEC

    Picture of Genscript Biotech logoGenscript Biotech
    14/04/2023 16:09
    April 14 (Reuters) - Genscript Biotech Corp  1548.HK :
    * LEGEND BIOTECH FILED A FORM 6-K WITH U.S. SEC
    * LEGEND BIOTECH USA & JANSSEN RESEARCH + DEVELOPMENT &
NOVARTIS
PHARMACEUTICALS CORP ENTERED MASTER TECHNOLOGY TRANSFER
    * LEGEND ENTERED DEAL FOR MANUFACTURING CILTACABTAGENE
AUTOLEUCEL
TO SUPPLEMENT COLLABORATION PARTNERS' MANUFACTURING CAPABILITIES


Further company coverage:  1548.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Genscript Biotech

    See all news